Page last updated: 2024-08-26

arsenic and Human T-lymphotropic Virus 1 Infection

arsenic has been researched along with Human T-lymphotropic Virus 1 Infection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazarbachi, A; Berry, F; Dassouki, Z; de Thé, H; El Hajj, H; Ezzedine, M; Farid, R; Ghantous, A; Ghavamzadeh, A; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Mortada, M; Nasser, R; Rafatpanah, H; Rahimi, H; Rezaee, R; Shirdel, A; Tarhini, M1
Abe, Y; Kamada, H; Minowa, K; Nabeshi, H; Nagano, K; Nomura, T; Shibata, H; Sugita, T; Tsunoda, S; Tsutsumi, Y; Yoshikawa, T1
Bazarbachi, A; Fields, P; Hermine, O; Suarez, F1
Bazarbachi, A; Contamin, H; de Thé, H; Gessain, A; Heraud, JM; Hermine, O; Kazanji, M; Mahieux, R; Merien, F; Mortreux, F; Pouliquen, JF; Wattel, E1
Arima, T; Chyuman, Y; Hanada, S; Ishitsuka, K; Makino, T; Shimotakahara, S; Suzuki, S; Takeshita, T; Takeuchi, S; Uozumi, K; Utsunomiya, A1
Gallo, RC1

Reviews

1 review(s) available for arsenic and Human T-lymphotropic Virus 1 Infection

ArticleYear
Research and discovery of the first human cancer virus, HTLV-1.
    Best practice & research. Clinical haematology, 2011, Volume: 24, Issue:4

    Topics: Adult; Animals; Antiviral Agents; Arsenic; Cell Proliferation; Cell Transformation, Viral; Host-Pathogen Interactions; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Transgenic; Viral Proteins; Virus Replication; Zidovudine

2011

Other Studies

5 other study(ies) available for arsenic and Human T-lymphotropic Virus 1 Infection

ArticleYear
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
    Retrovirology, 2013, Aug-20, Volume: 10

    Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Cytokines; Female; Gene Expression Profiling; HTLV-I Infections; Humans; Immunologic Factors; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Prospective Studies; Treatment Outcome; Zidovudine

2013
Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
    Die Pharmazie, 2010, Volume: 65, Issue:9

    Topics: Arsenic Trioxide; Arsenicals; Cell Fusion; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Endoplasmic Reticulum Chaperone BiP; Gels; Gene Products, env; HeLa Cells; HTLV-I Infections; Humans; Hydrolysis; Immunoprecipitation; Oxidation-Reduction; Oxides; Proteomics; Retroviridae Proteins, Oncogenic; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trypsin

2010
How I treat adult T-cell leukemia/lymphoma.
    Blood, 2011, Aug-18, Volume: 118, Issue:7

    Topics: Anti-Retroviral Agents; Antibodies, Monoclonal; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Oxides

2011
The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).
    Antiviral research, 2006, Volume: 70, Issue:3

    Topics: Animals; Antiviral Agents; Arsenic Trioxide; Arsenicals; Cell Line, Transformed; Drug Therapy, Combination; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Male; Oxides; Saimiri; Treatment Outcome

2006
Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids.
    British journal of haematology, 1998, Volume: 103, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Oxides; T-Lymphocytes; Tretinoin; Tumor Cells, Cultured

1998